Herborium Announces 16th Quarter of Sales Growth and 4th Quarter Outlook
Herborium Group, Inc. (OTCMKTS:HBRM), a Botanical Therapeutics Company and the provider of unique all botanical medicinal products (Botanical Therapeutics) that target dermatological issues such as acne, and other health and wellness concerns, announced today its results for the 9 month period ending August 30, 2017. For the 9 month period the Company achieved revenue growth of 8% to $672,000, and gross margins increase 8.9% to $412,000. Additionally, the Company has maintained a 61% gross profit margin. This marks the consecutive 16th...
View full press release